Compliance checklist

The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Seeks Industry Partners for Clinical Research Collaborations on Therapeutics, Diagnostics or Devices for Childhood Cholestatic Liver Diseases · RFA-DK-23-017_RFA-DK-23-018. 2 requirement sentences found in the notice: every "shall", "must" and "required", quoted as written and sorted into submission requirements (0) and performance / contract clauses (2). Nothing is generated.

Pro

The full checklist is a Pro feature

2 requirement sentences on this RFP. Pro shows every one, grouped by section, with a CSV export, for $39/mo. Below is a preview.

Submission requirements · 0

None found.

Performance / contract clauses · 2

Notice · 2

Evaluate the use of cytokine assays for analyses of serum/plasma cytokine levels as markers of disease activity and as surrogate markers of histologic or clinical improvement in therapeutic trials CAPABILITY STATEMENT: Commercial organizations interested in pursuing clinical collaborations with NIDDK for childhood cholestatic liver diseases are required to submit a Capability Statement to NIDDK.
(Note: The proposed therapeutic or device must have been tested already in a Phase I trial in humans.) 2.

Extracted from the notice text and attachments as published. The solicitation governs; read Sections L and M in full before you submit.